From: Five-year follow-up of mitral valve repair versus replacement: a propensity score analysis
 | Repair (N = 64) | Replacement (N = 64) | P value |
---|---|---|---|
Age (years) | 70.5 (42–86) | 71.5 (48–88) | 0.75 |
Gender (n, %) female | 30 (46.9%) | 32 (50%) | 0.72 |
Weight (kg) | 79.5 (54–115) | 77.5 (47–138) | 0.90 |
Past history | |||
 Coronary heart disease (n, %) | 25 (29.1%) | 24 (37.5%) | 0.86 |
 Atrial fibrillation (n, %) | 30 (46.9%) | 33 (51.6%) | 0.60 |
 COPDa/Asthma bronchial (n, %) | 8 (12.5%) | 16 (25%) | 0.07 |
 Myocardial infarction (n, %) | 2 (3.1%) | 6 (9.4%) | 0.27 |
 Previous cardiac surgery (n, %) | 1 (1.6%) | 1 (1.6%) | 1.00 |
 Stroke (n, %) | 2 (3.1%) | 7 (10.9%) | 0.16 |
Ejection Fraction ≥ 50% (n, %) | 46 (71.9%) | 51 (79.7%) | 0.43 |
NYHAb classification | |||
 I | 6 (9.4%) | 8 (12.5%) | 0.36 |
 II | 11 (17.2%) | 5 (7.8%) |  |
 III | 30 (46.9%) | 36 (56.3%) |  |
 IV | 17 (26.5%) | 15 (23.4%) |  |
Risk factors | |||
 Diabetes mellitus (n, %) | 8 (12.5%) | 14 (21.9%) | 0.16 |
 Hypertension (n, %) | 51 (79.7%) | 54 (84.4%) | 0.49 |
 Obesity (n, %) | 22 (34.4%) | 27 (42.2%) | 0.36 |
 Smoking (n, %) | 13 (20.3%) | 22 (34.4%) | 0.07 |
 Hyperlipidaemia (n, %) | 17 (26.5%) | 24 (37.5%) | 0.18 |